X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.290
+0.150 (3.62%)
Apr 17, 2026, 4:00 PM EDT - Market closed
X4 Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$9.00
Upside
+109.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +179.72% | Mar 9, 2026 |
| Stifel | Stifel | Strong Buy Maintains $7.5 → $10 | Strong Buy | Maintains | $7.5 → $10 | +133.10% | Dec 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3.5 → $5 | Strong Buy | Maintains | $3.5 → $5 | +16.55% | Nov 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $30 → $9 | Strong Buy | Maintains | $30 → $9 | +109.79% | Aug 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3.5 | Strong Buy | Maintains | $7 → $3.5 | -18.41% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $7 | Strong Buy | Maintains | $1.5 → $7 | +63.17% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +948.95% | Mar 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $90 | Buy | Reiterates | $90 | +1,997.90% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +948.95% | Feb 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +948.95% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $45 | Strong Buy | Maintains | $150 → $45 | +948.95% | Nov 14, 2024 |
| Stifel | Stifel | Strong Buy Maintains $150 → $120 | Strong Buy | Maintains | $150 → $120 | +2,697.20% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +3,396.50% | Jun 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $150 | Buy | Reiterates | $150 | +3,396.50% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $150 | Strong Buy | Maintains | $90 → $150 | +3,396.50% | Apr 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +1,997.90% | Mar 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.